Cost-effectiveness analysis of the use of faricimab in diabetic macular edema in China
Aim: Diabetic macular edema (DME) is one of the leading causes of vision impairment in diabetic patients. The aim of this study was to evaluate the cost-effectiveness of faricimab (Vabysmo R ), the first bispecific antibody targeting VEGF-A and ANG-2, for treating DME in China. Materials & method...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Becaris Publishing Limited
2026-03-01
|
| coleção: | Journal of Comparative Effectiveness Research |
| Assuntos: | |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|